Ninatoka
Concept enzyme

CYP2C9


CYP2C9 is a major cytochrome P450 enzyme that is involved in the metabolic clearance of a wide variety of therapeutic agents, including nonsteroidal antiinflammatories, oral anticoagulants, and oral hypoglycemics.

Ref:
Rettie AE, Jones JP. Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. Annu Rev Pharmacol Toxicol. 2005;45:477-94. doi: 10.1146/annurev.pharmtox.45.120403.095821. PMID: 15822186.

20 confidence points 
0 comments
 Added on Sep 8, 2023 by Barbara Van De Keer
Edited on Sep 8, 2023 by Barbara Van De Keer

Join Ninatoka!!


NinatoKa's goal is to support you as a therapist in unravelling the illness pathway from symptoms to cause, and to help you detect potential interventions.

Go to Explore to start your discovery!

Go to Learn to scroll through newly added data.

Go to Contribute to contribute to the Ninatoka database.

You can rate content up or down and add comments if you agree or disagree.

Log in

Sign up